Effectiveness and safety of long-acting versus short acting methylphenidate in ADHD in population between 6 and 19 years: a systematic review
Introduction: Attention deficit hyperactivity disorder (ADHD) is generally treated with short-acting methylphenidate, but recently a long-acting presentation has been introduced, hence the interest of the study to evaluate the two formulations. Purpse: To identify, synthesize and evaluate the best a...
Main Authors: | José Calleja, José Uribarri |
---|---|
Format: | Article |
Language: | English |
Published: |
Medwave Estudios Limitada
2012-09-01
|
Series: | Medwave |
Subjects: | |
Online Access: | http://dx.doi.org/10.5867/medwave.2012.08.5476 |
Similar Items
-
Effectiveness and safety of methylphenidate for ADHD in population between 6 and 19 years: a systematic review
by: José Calleja, et al.
Published: (2012-09-01) -
Methylphenidate for ADHD in Preschoolers
by: J Gordon Millichap
Published: (1997-11-01) -
TICS, Methylphenidate, and ADHD
by: J Gordon Millichap
Published: (1999-08-01) -
Response Prediction to Methylphenidate in ADHD
by: J Gordon Millichap
Published: (1995-08-01) -
Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD
by: Stéphanie Bioulac, et al.
Published: (2019-08-01)